Tabula Rasa HealthCare, Inc.
TRHC · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.25 | 0.51 | -0.08 | 0.84 |
| FCF Yield | -17.78% | -5.65% | -1.83% | -2.89% |
| EV / EBITDA | -15.68 | -32.96 | -59.06 | 745.67 |
| Quality | ||||
| ROIC | -19.90% | -16.24% | -11.71% | -4.21% |
| Gross Margin | 22.34% | 29.56% | 31.09% | 36.30% |
| Cash Conversion Ratio | -0.05 | -0.20 | -0.06 | 0.18 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.26% | 5.18% | 13.32% | 28.38% |
| Free Cash Flow Growth | -8.29% | -15.39% | 40.96% | -651.54% |
| Safety | ||||
| Net Debt / EBITDA | -10.80 | -16.80 | -13.14 | 128.65 |
| Interest Coverage | -6.24 | -7.61 | -2.78 | -1.80 |
| Efficiency | ||||
| Inventory Turnover | 35.43 | 42.86 | 48.07 | 49.01 |
| Cash Conversion Cycle | 23.19 | 37.83 | 45.18 | 27.43 |